To assess whether the addition of Extra-corporeal Shockwave Therapy (ESWT) to a structured home-exercise programme has any additional benefit to patients with tendinopathies
This involves patients with one of 6 different defined chronic tendinopathies. These individual sites are run as discrete sub-studies, with randomisation n occurring within sub-study grouping
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
720
The use of ESWT from a commercially available machine at approved settings already in routine clinical use
a structured and standardised rehabilitation programme specific to the tendon in question - already in routine clinical use
University Hospitals of Leicester NHS Trust
Leicester, United Kingdom
RECRUITINGimprovement in pain as assessed by a 0-10 visual analogue scale (VAS)
Time frame: primary outcome 3 months
improvement in pain as assessed by a 0-10 visual analogue scale (VAS)
Time frame: secondary outcome at 6 months post treatment
improvement in function as assessed by several validated patient-rated outcome measures
These will use validated patient-rated outcome measures (PROMS) already in routine use in this clinical service. This include specific site questions, for example patella tendon (VISA-P), achilles tendon (VISA-A), trochanteric pain (Oxford Hip Score, Non-Arthritic Hip Score), plantar fascia (revised foot function index, MOXFQ) all of which give a wider picture of the outcome of specific conditions. these are all fully detailed in the study protocol.
Time frame: 3 months and 6 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.